| Previous Close | 0.0001 |
| Open | 0.0001 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0001 - 0.0001 |
| 52 Week Range | 0.0000 - 0.4998 |
| Volume | 2,000,130 |
| Avg. Volume | 3,830,195 |
| Market Cap | 447,435 |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
SAN FRANCISCO, CA, Nov. 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”), announces today that Proscere Bioscience has secured the rights to manufacture a CBD - Hybrid Extraction System with integrated cold-water and alcohol extraction technologies. Proscere Bioscience will manufacture the world’s first Hybrid Cold-Water/Alcohol Extraction System for CBD. Richard Hylen, CEO, stated, “Having secured the technological rights to build and bring to market the world’s first Hybrid Extraction System for CBD is certainly a game changer for the Company.
San Francisco, California, Oct. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”), Richard Hylen, Chairman and CEO, has made the following announcement. “In the past year Simlatus has acquired Satel Group and Proscere Bioscience. With this said, I was appointed as the Chairman and CEO of Simlatus on October 31, 2018.
San Francisco, California, Oct. 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) announces today that Proscere Bioscience will have the rights to manufacture a hybrid CBD Extraction System which combines cold-water extraction with alcohol extraction. Richard Hylen, CEO, stated, “We now have the technology rights to build a CBD extraction system that can process bio-mass through a cold-water extraction processing system first, and through an alcohol extraction system second.
San Francisco, California, Oct. 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) announces today that certifications and manufacturing processes are initiated to commence the manufacturing and delivery pursuant the purchase orders for the CBD Extraction Systems. Safe Harbor for Forward-Looking Statements: This news release contains forward-looking statements which are not statements of historical fact.
San Francisco, California, Sept. 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) announces today that between March and August of this year it has prepaid 5 notes for a total principal, interest and penalties of over $2M. Pursuant the 8K filing of September 16, 2019, the company is finalizing the delivery of 14 CBD Extraction Systems in value of $24M. Richard Hylen, CEO, stated, “Whenever possible, we have been prepaying convertible notes and retiring any reserves and shares back to treasury.
Grass Valley, CA, Sept. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) ("Simlatus" or the "Company") announces today negotiations with a major pharmaceutical company in Europe regarding a potential $200M initial order. The company initially discussed its Hybrid Cold/Water – Alcohol based CBD Extraction system in Europe last December-2018 with a major pharmaceutical company. Negotiations are gaining ground while Proscere Bioscience is positioning itself to supply the pharmaceutical industry with CBD extraction systems to produce pharmaceutical-grade THC and CBD as a replacement for opiate based Schedule-II prescription drugs.
Richard Hylen, CEO and Chairman, stated, “Since my appointment starting in late 2018 , our company has demonstrated growth in revenue and sales for all 3 of our subsidiaries. Mr. Hylen further stated, “Proscere Bioscience continues to demonstrate strong growth in the growing CBD industry, with our focus on fulfilling $20M+ in purchase orders for our CBD Extraction systems.
San Francisco, California, Aug. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) today announces that the Company entered into a Release Agreement in July 2019 and agreed to pre-pay the entire balance of a convertible note dated January 31, 2019 with the original principal amount of $33,000 between Emunah Funding, LLC and SIML. About SIML: While acquisitions of companies in the hemp sector accelerate worldwide as industrial and consumer hemp/CBD markets develop, our Proscere Bioscience is the company’s division focused on the CBD industry with sales over $20M during the first half of 2019 for its Cold-Water Extraction System. Satel Group is one of only a handful of companies holding AT&T contracts to service multi-dwelling units throughout large metropolitan areas in the USA with DirecTV services.
San Francisco, California, July 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) is a holding company focused on opportunities in the cannabis space. The Company owns and operates a number of subsidiaries with multiple revenue streams. While acquisitions of companies in the hemp sector accelerate worldwide as industrial and consumer hemp/CBD markets develop, our Proscere Bioscience is the company’s division focused on the CBD industry.
San Francisco, California, July 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) is a holding company focused on opportunities in the cannabis space. The Company owns and operates a number of subsidiaries with multiple revenue streams. While acquisitions of companies in the hemp sector accelerate worldwide as industrial and consumer hemp/CBD markets develop, our Proscere Bioscience is the company’s division focused on the CBD industry.
Point Roberts, Washington and Delta, British Columbia--(Newsfile Corp. - July 9, 2019) - Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a multimedia snapshot reporting on the movement surrounding CBD/hemp business acquisitions based on continued growth in consumer and industrial demand in both the US and internationally. Read the full article on Investorideas.com https://www.investorideas.com/News/2019/cannabis/07090CBD-Hemp.aspFior Markets said in its recent report, 'the global industrial hemp market is expected to grow ...
San Francisco, California, July 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) is a holding company focused on opportunities in the cannabis space. The Company owns and operates a number of subsidiaries with multiple revenue streams. While acquisitions of companies in the hemp sector accelerate worldwide as industrial and consumer hemp/CBD markets develop, our Proscere Bioscience is the company’s division focused on the CBD industry.
Point Roberts, Washington and Delta, British Columbia--(Newsfile Corp. - July 1, 2019) - Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a multi-media snapshot reporting on recent acquisitions in the CBD cannabis space, featuring Simlatus Corporation (OTC PINK: SIML).Read the full article discussing acquisitions in the CBD cannabis space on Investorideas.com https://www.investorideas.com//News/2019/cannabis/07010Acquisitions.aspViridian's Deal Tracker recently noted, "Acquisitions of companies in the hemp sector accelerate worldwide as industrial and ...
SAN FRANCISCO, CA, July 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) is a holding company focused on opportunities in the cannabis space. The Company owns and operates a number of subsidiaries with multiple revenue streams in the CBD industry. Proscere Bioscience is the company’s division focused on the CBD industry.
SAN FRANCISCO, CA, June 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”), a company that operates multiple revenue streams in the CBD Industry, Major Broadcast Industry and Internet Provider Industry, announces today that Chairman and CEO, Richard Hylen, has provided the following statements. Richard Hylen, Chairman and CEO, stated, “Simlatus Corporation is no longer considered a Shell-Risk by OTC Markets. The Company’s most recent disclosure statements and Balance Sheet indicate satisfactory revenue and assets. We need to prove to our shareholders and investors a vote of confidence by the Markets and that our Company is on a sound path for the future.
Pursuant with the Form-8K filed today, the company has settled and retired to treasury approximately $600,000 in convertible debt. Richard Hylen, Chairman and CEO, stated, “I listen to our shareholders and pay attention to our market concerns.
Richard Hylen, Chairman and CEO, stated, “I received a commercial purchase order from United Opportunities, LLC on May 28, 2019 to manufacture 4 Cold-Water CBD/HEMP Extraction Systems for one of their customers in the amount of $2,880,000. Satel is now receiving additional MDU properties for DirecTV and Internet services.
San Francisco, California, May 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK:SIML) (“Simlatus” or the “Company”), a company that operates multiple revenue streams in the CBD Industry, Major Broadcast Industry and Internet Provider Industry announces the completion and disclosure filing of its audited annual financial statements post-merger and first-quarter financial statements for 2019. Prior to our merger Satel has been in operations for approximately 20 years as a privately held company.
San Francisco, CA, April 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK:SIML) (“Simlatus” or the “Company”), the company announces that pursuant with the filing of our Form 10-KT for the period ending December 31, 2018, the Company will require additional time to complete the audit procedures based upon the facts that the merger took place in November 2018, and the issuer had changed its year-end from March 31 to December 31. The Company was required to file the Form-10KT on or before March 31, 2019, and had filed an extension Form NT 10-K on April 1, 2019 for filing on or before April 16, 2019. The company anticipates filing in the very near future once all of the audit procedures are complete. Richard Hylen, CEO and Chairman, stated, “Our merger took place in the fourth quarter of 2018, while the company changed its year-end filing date from March 31 to December 31.